Cambridge, MA, United States of America

Toni Kline

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 110(Granted Patents)


Location History:

  • New York, NY (US) (1993)
  • Cambridge, MA (US) (1995 - 1997)

Company Filing History:


Years Active: 1993-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Toni Kline

Introduction

Toni Kline is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of novel therapeutic agents. With a total of three patents to her name, Kline's work focuses on innovative methods for coating invasive devices.

Latest Patents

One of her latest patents is titled "Methods for coating invasive devices with inhibitors of thrombin." This invention relates to novel biologically active molecules that bind to and inhibit thrombin. Specifically, these molecules are characterized by a thrombin anion-binding exosite association moiety (ABEAM), a linker portion of at least 18 .ANG. in length, and a thrombin catalytic site-directed moiety (CSDM). This invention also encompasses compositions, combinations, and methods that employ these molecules for therapeutic, prophylactic, and diagnostic purposes.

Career Highlights

Throughout her career, Toni Kline has worked with prominent companies such as Biogen, Incorporated and Health Research, Inc. Her expertise in the field has led to advancements that have the potential to improve patient outcomes in various medical applications.

Collaborations

Kline has collaborated with notable individuals in her field, including John M. Maraganore and John W. Fenton, II. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Toni Kline's contributions to the field of biomedical engineering through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical technology and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…